Depressive symptoms and quality of life in adolescents with type 2 diabetes: baseline data from the TODAY study
Barbara J Anderson, Sharon Edelstein, Natalie Walders Abramson, Lorraine E Levitt Katz, Patrice M Yasuda, Sylvia J Lavietes, Paula M Trief, Sherida E Tollefsen, Siripoom Vudhipoom McKay, Patricia Kringas, Terri Lynn Casey, Marsha D Marcus, Barbara J Anderson, Sharon Edelstein, Natalie Walders Abramson, Lorraine E Levitt Katz, Patrice M Yasuda, Sylvia J Lavietes, Paula M Trief, Sherida E Tollefsen, Siripoom Vudhipoom McKay, Patricia Kringas, Terri Lynn Casey, Marsha D Marcus
Abstract
Objective: The study objective was to examine the prevalence of depressive symptoms and relationships to quality of life and demographics in the Treatment Options for Type 2 Diabetes in Adolescents and Youth (TODAY) study's large, ethnically diverse youth with type 2 diabetes.
Research design and methods: A total of 704 youth with type 2 diabetes <2 years' duration, aged 10-17 years, and BMI ≥85th percentile completed depressive symptoms and quality of life measures.
Results: Some 14.8% reported clinically significant depressive symptoms, and older girls had significantly higher rates than older boys.
Conclusions: Rates of significant depressive symptoms were similar to those of healthy adolescents and lower than those of teens with type 1 diabetes. Elevated depressive symptoms, particularly in older girls, suggest clinicians assess vulnerability.
Trial registration: ClinicalTrials.gov NCT00081328.
References
- Anderson RJ, Freedland KE, Clouse RE, Lustman PJ. The prevalence of comorbid depression in adults with diabetes: a meta-analysis. Diabetes Care 2001;24:1069–1078
- Lin EHB, Rutter CM, Katon W, et al. Depression and advanced complications of diabetes: a prospective cohort study. Diabetes Care 2010;33:264–269
- Copeland KC, Zeitler P, Geffner M, et al. Characteristics of adolescents and youth with recent-onset type 2 diabetes: the TODAY cohort at baseline. J Clin Endocrinol Metab 2011;96:159–167
- Kovacs M. Children’s Depression Inventory. New York, Multi-Health Systems, 1992
- Beck AT, Steer RA, Brown GK. Manual for the Beck Depression Inventory-II. San Antonio, TX, Psychological Corporation, 1996
- Varni JW, Seid M, Rode CA. The PedsQL: measurement model for the Pediatric Quality of Life inventory. Med Care 1999;37:126–139
- Kessler RC, Avenevoli S, Ries Merikangas K. Mood disorders in children and adolescents: an epidemiologic perspective. Biol Psychiatry 2001;49:1002–1014
- Dabelea D, Bell RA, D’Agostino RB, Jr, et al. ; Writing Group for the SEARCH for Diabetes in Youth Study Group Incidence of diabetes in youth in the United States. JAMA 2007;297:2716–2724
- Liese AD, D’Agostino RB, Jr, Hamman RF, et al. ; SEARCH for Diabetes in Youth Study Group The burden of diabetes mellitus among US youth: prevalence estimates from the SEARCH for Diabetes in Youth Study. Pediatrics 2006;118:1510–1518
- Hankin BL, Abramson LY, Moffitt TE, Silva PA, McGee R, Angell KE. Development of depression from preadolescence to young adulthood: emerging gender differences in a 10-year longitudinal study. J Abnorm Psychol 1998;107:128–140
- Lawrence JM, Standiford DA, Loots B, et al. ; SEARCH for Diabetes in Youth Study Prevalence and correlates of depressed mood among youth with diabetes: the SEARCH for Diabetes in Youth study. Pediatrics 2006;117:1348–1358
- Grey M, Whittemore R, Tamborlane W. Depression in type 1 diabetes in children: natural history and correlates. J Psychosom Res 2002;53:907–911
- Hood KK, Huestis S, Maher A, Butler D, Volkening L, Laffel LM. Depressive symptoms in children and adolescents with type 1 diabetes: association with diabetes-specific characteristics. Diabetes Care 2006;29:1389–1391
- Kovacs M, Obrosky DS, Goldston D, Drash A. Major depressive disorder in youths with IDDM. A controlled prospective study of course and outcome. Diabetes Care 1997;20:45–51
- Rubin RR, Ciechanowski P, Egede LE, Lin EH, Lustman PJ. Recognizing and treating depression in patients with diabetes. Curr Diab Rep 2004;4:119–125
Source: PubMed